p63/TP73L Antibody (TP63/2427) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08735PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin, Protein Array
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # TP63/2427
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for p63/TP73L Antibody (TP63/2427) [PerCP]
Immunogen
Recombinant full-length human p63/TP73L protein (Uniprot: Q9H3D4)
Localization
Nuclear
Marker
Squamous, Basal & Myoepithelial Cell Marker
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for p63/TP73L Antibody (TP63/2427) [PerCP]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Protein Array
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: p63/TP73L
Long Name
Tumor Protein 63
Alternate Names
EEC3, KET, OFC8, p40, p51, p73L, SHFM4, TP63, TP73L
Gene Symbol
TP63
Additional p63/TP73L Products
Product Documents for p63/TP73L Antibody (TP63/2427) [PerCP]
Product Specific Notices for p63/TP73L Antibody (TP63/2427) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...